Challenges in research related to perioperative cancer care and cancer outcomes

Best Practice and Research: Clinical Anaesthesiology

Volumn 27, Issue 4, 2013, Pages 457-464

  Cata, Juan P ^a   Kurz, Andrea ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

cancer; clinical research; perioperative medicine; randomised control trial

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER RESEARCH; CANCER SURGERY; CANCER SURVIVAL; HUMAN; IMMUNE DEFICIENCY; NEOPLASM; OUTCOMES RESEARCH; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; REGIONAL ANESTHESIA; SURVIVAL RATE;

CANCER; CLINICAL RESEARCH; PERIOPERATIVE MEDICINE; RANDOMISED CONTROL TRIAL;

ANESTHESIA, CONDUCTION; ANIMALS; BIOMEDICAL RESEARCH; HUMANS; IMMUNOCOMPROMISED HOST; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS; PERIOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL RATE; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84888435943     PISSN: 15216896     EISSN: 1532169X     Source Type: Journal    
DOI: 10.1016/j.bpa.2013.10.004     Document Type: Review

References (61)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 1 62 2012 10 29
2. R. Siegel, C. DeSantis, and K. Virgo Cancer treatment and survivorship statistics, 2012 CA Cancer J Clin 4 62 2012 220 241
3. N. Sung, W. Crowley, and M. Genel Central challenges facing the national clinical research enterprise JAMA 10 289 2003 1278 1287
4. J.P. Cata, V. Gottumukkala, and D.I. Sessler How regional analgesia might reduce postoperative cancer recurrence Eur J Pain Suppl 2 5 2011 345 355
5. J.P. Cata, H. Wang, and V. Gottumukkala Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions Br J Anaesth 5 110 2013 690 701
6. S. Bar-Yosef, R. Melamed, and G.G. Page Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats Anesthesiology 6 94 2001 1066 1073
7. Y. Goldfarb, L. Sorski, and M. Benish Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses Ann Surg 4 253 2011 798 810
8. R. Melamed, S. Bar-Yosef, and G. Shakhar Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures Anesth Analg 5 97 2003 1331 1339
9. E.K. Sloan, S.J. Priceman, and B.F. Cox The sympathetic nervous system induces a metastatic switch in primary breast cancer Cancer Res 18 70 2010 7042 7052
10. A.K. Sood, R. Bhatty, and A.A. Kamat Stress hormone-mediated invasion of ovarian cancer cells Clin Cancer Res 2 12 2006 369 375
11. S. Ben-Eliyahu, G.G. Page, and R. Yirmiya Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity Int J Cancer 6 80 1999 880 888
12. S. Ben-Eliyahu, G. Shakhar, and G.G. Page Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors Neuroimmunomodulation 3 8 2000 154 164
13. M. Benish, I. Bartal, and Y. Goldfarb Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis Ann Surg Oncol 7 15 2008 2042 2052
14. A. Glasner, R. Avraham, and E. Rosenne Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor J Immunol 5 184 2010 2449 2457
15. K. Greenfeld, R. Avraham, and M. Benish Immune suppression while awaiting surgery and following it: dissociations between plasma cytokine levels, their induced production, and NK cell cytotoxicity Brain Behav Immun 4 21 2007 503 513
16. G.G. Page, and S. Ben-Eliyahu Natural killer cell activity and resistance to tumor metastasis in prepubescent rats: deficient baselines, but invulnerability to stress and beta-adrenergic stimulation Neuroimmunomodulation 3 7 2000 160 168
17. H. Wada, S. Seki, and T. Takahashi Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance Anesthesiology 3 106 2007 499 506
18. M. Looney, P. Doran, and D. Buggy Effect of anesthetic technique on serum vascular endothelial growth factor C and transforming growth factor β in women undergoing anesthesia and surgery for breast cancer Anesthesiology 5 113 2010 1118 1125
19. C.A. Deegan, D. Murray, and P. Doran Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery Reg Anesth Pain Med 6 35 2010 490 495
20. J.P. Cata, M. Bauer, and T. Sokari Effects of surgery, general anesthesia, and perioperative epidural analgesia on the immune function of patients with non-small cell lung cancer J Clin Anesth 25 4 2013 255 262
21. H. Dong, Y. Zhang, and H. Xi The effects of epidural anaesthesia and analgesia on natural killer cell cytotoxicity and cytokine response in patients with epithelial ovarian cancer undergoing radical resection J Int Med Res 5 40 2012 1822 1829
22. I. Conrick-Martin, M.R. Kell, and D.J. Buggy Meta-analysis of the effect of central neuraxial regional anesthesia compared with general anesthesia on postoperative natural killer T lymphocyte function J Clin Anesth 1 24 2012 3 7
23. S.K. Ramachandran, and S. Kheterpal Outcomes research using quality improvement databases: evolving opportunities and challenges Anesthesiol Clin 1 29 2011 71 81
24. G. Porter, and J. Skibber Outcomes research in surgical oncology Ann Surg Oncol 5 7 2000 367 375
25. R.E. Freundlich, and S. Kheterpal Perioperative effectiveness research using large databases Best Pract Res Clin Anaesthesiol 4 25 2011 489 498
26. H. Nathan, and T. Pawlik Limitations of claims and registry data in surgical oncology research Ann Surg Oncol 2 15 2008 415 423
27. B. Biki, E. Mascha, and D.C. Moriarty Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis Anesthesiology 2 109 2008 180 187
28. A.K. Exadaktylos, D.J. Buggy, and D.C. Moriarty Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 4 105 2006 660 664
29. W.-K. Chen, and C.-H. Miao The effect of anesthetic technique on survival in human cancers: a meta-analysis of retrospective and prospective studies PLoS One 2 8 2013
30. M. Binczak, E. Tournay, and V. Billard Major abdominal surgery for cancer: does epidural analgesia have a long-term effect on recurrence-free and overall survival? Ann françaises d'anesthèsie de rèanimation 5 32 2013 8
31. A. Day, R. Smith, and I. Jourdan Retrospective analysis of the effect of postoperative analgesia on survival in patients after laparoscopic resection of colorectal cancer Br J Anaesth 2 109 2012 185 190
32. A. Gupta, A. Bjornsson, and M. Fredriksson Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: a retrospective analysis of data from 655 patients in central Sweden Br J Anaesth 2 107 2011 164 170
33. P.Y. Wuethrich, S.F. Hsu Schmitz, and T.M. Kessler Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: a retrospective study Anesthesiology 3 113 2010 570 576
34. R. Lai, Z. Peng, and D. Chen The effects of anesthetic technique on cancer recurrence in percutaneous radiofrequency ablation of small hepatocellular carcinoma Anesth Analg 2 114 2012 290 296
35. A. Gottschalk, J. Ford, and C. Regelin Association between epidural analgesia and cancer recurrence after colorectal cancer surgery Anesthesiology 1 113 2010 27 34
36. B. Tsui, S. Rashiq, and D. Schopflocher Epidural anesthesia and cancer recurrence rates after radical prostatectomy Can J Anaesth = J canadien d'anesthésie 2 57 2010 107 112
37. P. Myles, P. Peyton, and B. Silbert Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial BMJ (Clinical Research ed.) 2011 342
38. K.C. Cummings 3rd, F. Xu, and L.C. Cummings A comparison of epidural analgesia and traditional pain management effects on survival and cancer recurrence after colectomy: a population-based study Anesthesiology 4 116 2012 797 806
39. P. Austin, M. Mamdani, and T. Stukel The use of the propensity score for estimating treatment effects: administrative versus clinical data Stat Med 10 24 2005 1563 1578
40. I. White, and P. Royston Imputing missing covariate values for the Cox model Stat Med 15 28 2009 1982 1998
41. C. Croy, and D. Novins Methods for addressing missing data in psychiatric and developmental research J Am Acad Child Adolesc Psychiatry 12 44 2005 1230 1240
42. P. Jüni, D. Altman, and M. Egger Systematic reviews in health care: assessing the quality of controlled clinical trials BMJ (Clinical Research ed.) 7303 323 2001 42 46
43. G.H. Guyatt, A.D. Oxman, and R. Kunz What is "quality of evidence" and why is it important to clinicians? BMJ 7651 336 2008 995 998
44. D. Moher, B. Pham, and A. Jones Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 9128 352 1998 609 613
45. K. Huwiler-Müntener, P. Jüni, and C. Junker Quality of reporting of randomized trials as a measure of methodologic quality JAMA 21 287 2002 2801 2804
46. J. Lachin Introduction to sample size determination and power analysis for clinical trials Controlled Clin Trials 2 2 1981 93 113
47. H. Stolberg, G. Norman, and I. Trop Randomized controlled trials AJR Am J Roentgenol 6 183 2004 1539 1544
48. N. Black Why we need observational studies to evaluate the effectiveness of health care BMJ 7040 312 1996 1215 1218
49. P. Glasziou, I. Chalmers, and M. Rawlins When are randomised trials unnecessary? Picking signal from noise BMJ 7589 334 2007 349 351
50. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009
51. J. Llovet, S. Ricci, and V. Mazzaferro Sorafenib in advanced hepatocellular carcinoma N Engl J Med 4 359 2008 378 390
52. A. Adjei, M. Christian, and P. Ivy Novel designs and end points for phase II clinical trials Clin Cancer Res 6 15 2009 1866 1872
53. J. Bogaerts, F. Cardoso, and M. Buyse Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial Nat Clin Pract Oncol 10 3 2006 540 551
54. M.J. van de Vijver, Y.D. He, and L.J. van't Veer A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 25 347 2002 1999 2009
55. Early Breast Cancer Trialists' Collaborative G Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 9472 365 2005 1687 1717
56. F. Cardoso, L. Van't Veer, and E. Rutgers Clinical application of the 70-gene profile: the MINDACT trial J Clin Oncol 5 26 2008 729 735
57. W. Curran, J. Schiller, and A. Wolkin Addressing the current challenges of non-small-cell lung cancer clinical trial accrual Clin Lung Cancer 4 9 2008 222 226
58. T. Albrecht, S. Eggly, and M. Gleason Influence of clinical communication on patients' decision making on participation in clinical trials J Clin Oncol 16 26 2008 2666 2673
59. O. Brawley The study of accrual to clinical trials: can we learn from studying who enters our studies? J Clin Oncol 11 22 2004 2039 2040
60. P. Castel, S. Négrier, and J.-P. Boissel Why don't cancer patients enter clinical trials? A review Eur J Cancer (Oxford, Engl 1990) 12 42 2006 1744 1748
61. S. Joffe, and J. Weeks Views of American oncologists about the purposes of clinical trials J Natl Cancer Inst 24 94 2002 1847 1853